Literature DB >> 30317428

Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.

Alma Faviola Favela-Mendoza1, Héctor Rangel-Villalobos1, Ingrid Fricke-Galindo2, Alberto Ortega-Vázquez2, Gabriela Martínez-Cortés1, Marisol López-López3.   

Abstract

The most widely studied polymorphisms of the ABCB1 gene are rs1128503 (c.1236C>T), rs2032582 (c.2677G>T/A), and rs1045642 (c.3435C>T). Although variation in ABCB1 allele frequencies among Mexican Mestizos (admixed) from different regions has been observed, Mexican Amerindians have been poorly studied. We aimed to describe the genetic variability of these three ABCB1 polymorphisms in a total sample of 273 Mexican volunteers that included Mestizos from the state of Yucatán, and Amerindians from seven populations (Tarahumara, Mayo, Huichol, Purépecha, Nahua, Tojolabal, and Maya). Genotypes were determined by means of Taq Man probes (qPCR). Genotype distribution was in Hardy-Weinberg equilibrium for all three ABCB1polymorphisms in the eight Mexican populations analyzed. For c.1236C>T and c.3435C>T, the heterozygous C/T was the most frequent genotype in the majority of the studied Mexican populations (range 30.8-65.4%), while heterozygous G/T was the most common genotype for c.2677G>T/A (range 25.9-51.2%), mainly followed by G/G (range 3.2-47.1%) and T/T (range 7.0-35.5%). 12 haplotypes were estimated from the three ABCB1 polymorphisms analyzed, with TTT the most frequent haplotype (mean, 37.0%). Genetic differentiation was demonstrated among the studied Mexican populations (Fst p value < 0.0001), which could imply a diverse drug response or a risk for adverse drug reactions to ABCB1 substrates. Although differences among Amerindians are probably due to genetic drift effects, for Mestizos this could imply variation in admixture composition. In conclusion, interpopulation variability in the observed frequencies of ABCB1 polymorphisms among Mexican Mestizos and Amerindians allow predicting diverse drug responses to ABCB1 substrates in these populations.

Entities:  

Keywords:  ABCB1; Amerindians; Mestizos; Mexican population; Pharmacogenetics; Polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30317428     DOI: 10.1007/s11033-018-4419-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

Review 1.  Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).

Authors:  Ingrid Fricke-Galindo; Helgi Jung-Cook; Adrián LLerena; Marisol López-López
Journal:  Drug Metab Pers Ther       Date:  2016-06-01

2.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.

Authors:  Irma Silva-Zolezzi; Alfredo Hidalgo-Miranda; Jesus Estrada-Gil; Juan Carlos Fernandez-Lopez; Laura Uribe-Figueroa; Alejandra Contreras; Eros Balam-Ortiz; Laura del Bosque-Plata; David Velazquez-Fernandez; Cesar Lara; Rodrigo Goya; Enrique Hernandez-Lemus; Carlos Davila; Eduardo Barrientos; Santiago March; Gerardo Jimenez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

3.  Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico.

Authors:  Rodrigo Rubi-Castellanos; Gabriela Martínez-Cortés; José Francisco Muñoz-Valle; Antonio González-Martín; Ricardo M Cerda-Flores; Manuel Anaya-Palafox; Héctor Rangel-Villalobos
Journal:  Am J Phys Anthropol       Date:  2009-07       Impact factor: 2.868

4.  MDR1 C3435T polymorphism in Mexican patients with breast cancer.

Authors:  N M Macías-Gómez; M Gutiérrez-Angulo; E Leal-Ugarte; L Ramírez-Reyes; J Peregrina-Sandoval; J P Meza-Espinoza; F Ramos Solano; M de la Luz Ayala-Madrigal; F Santoyo Telles
Journal:  Genet Mol Res       Date:  2014-07-04

5.  Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.

Authors:  Amy L Williams; Suzanne B R Jacobs; Hortensia Moreno-Macías; Alicia Huerta-Chagoya; Claire Churchhouse; Carla Márquez-Luna; Humberto García-Ortíz; María José Gómez-Vázquez; Noël P Burtt; Carlos A Aguilar-Salinas; Clicerio González-Villalpando; Jose C Florez; Lorena Orozco; Christopher A Haiman; Teresa Tusié-Luna; David Altshuler
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

6.  CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.

Authors:  Paulo C J L Santos; Renata A G Soares; Diogo B G Santos; Raimundo M Nascimento; George L L M Coelho; José C Nicolau; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2011-01-19       Impact factor: 2.103

7.  MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals.

Authors:  Evelia Leal-Ugarte; Melva Gutiérrez-Angulo; Nelly M Macías-Gómez; Valeria Peralta-Leal; Jorge Durán-González; María De La Luz Ayala-Madrigal; Miriam Partida-Pérez; Patricio Barros-Núñez; Dinorah Ruiz-Díaz; José M Moreno-Ortiz; Jorge Peregrina-Sandoval; Juan Pablo Meza-Espinoza
Journal:  Hum Biol       Date:  2008-08       Impact factor: 0.553

8.  Association study between the MDR1 gene and clinical characteristics in schizophrenia.

Authors:  Carlos A Tovilla-Zárate; Iván Vargas; Sandra Hernández; Ana Fresán; Alejandro Aguilar; Raúl Escamilla; Ricardo Saracco; Jorge Palacios; Beatriz Camarena
Journal:  Braz J Psychiatry       Date:  2014-06-10       Impact factor: 2.697

9.  SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis.

Authors:  Jinho Yoo; Youngbok Lee; Yujung Kim; Sun Young Rha; Yangseok Kim
Journal:  BMC Bioinformatics       Date:  2008-06-23       Impact factor: 3.169

10.  Genetic Polymorphisms Associated to Folate Transport as Predictors of Increased Risk for Acute Lymphoblastic Leukemia in Mexican Children.

Authors:  Fausto Zaruma-Torres; Ismael Lares-Asseff; Aurea Lima; Aarón Reyes-Espinoza; Verónica Loera-Castañeda; Martha Sosa-Macías; Carlos Galaviz-Hernández; María C Arias-Peláez; Miguel A Reyes-López; Luis A Quiñones
Journal:  Front Pharmacol       Date:  2016-08-05       Impact factor: 5.810

View more
  1 in total

1.  Bioinformatics in Mexico: A diagnostic from the academic perspective and recommendations for a public policy.

Authors:  Dagoberto Armenta-Medina; Christian Díaz de León-Castañeda; Brenda Valderrama-Blanco
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.